Non-alcoholic fatty liver disease: A sign of systemic disease.

Published

Journal Article (Review)

Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and leading cause of cirrhosis in the United States and developed countries. NAFLD is closely associated with obesity, insulin resistance and metabolic syndrome, significantly contributing to the exacerbation of the latter. Although NAFLD represents the hepatic component of metabolic syndrome, it can also be found in patients prior to their presentation with other manifestations of the syndrome. The pathogenesis of NAFLD is complex and closely intertwined with insulin resistance and obesity. Several mechanisms are undoubtedly involved in its pathogenesis and progression. In this review, we bring together the current understanding of the pathogenesis that makes NAFLD a systemic disease.

Full Text

Cited Authors

  • Reccia, I; Kumar, J; Akladios, C; Virdis, F; Pai, M; Habib, N; Spalding, D

Published Date

  • July 2017

Published In

Volume / Issue

  • 72 /

Start / End Page

  • 94 - 108

PubMed ID

  • 28641788

Pubmed Central ID

  • 28641788

Electronic International Standard Serial Number (EISSN)

  • 1532-8600

International Standard Serial Number (ISSN)

  • 0026-0495

Digital Object Identifier (DOI)

  • 10.1016/j.metabol.2017.04.011

Language

  • eng